References
- Attie-Bitach T., Abitbol M., Gerard M., Delezoide A.L., Auge J., Pelet A., Amiel J., Pachnis V., Munnich A., Lyonnet S., Vekemans M. Expression of the RET proto-oncogene in human embryos. Am. J. Med. Genet. 1998; 80: 481–6
- Ceccherini I., Bocciardi R., Luo Y., Pasini B., Hofstra R., Takahashi M., Romeo G. Exon structure and flanking intronic sequences of the human RET proto- oncogene. Biochem. Biophys. Res. Commun. 1993; 196: 1288–95
- Frohman M.A. Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. Methods Enzymol 1993; 218: 340–56
- Gestblom C, Sweetser D.A., Doggett B., Kapur R.P. Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)- transgenic mice. Am. J. Patho. 1 1999; 155: 2167–79
- Hardison R.C., Oeltjen J., Miller W. Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. Genome Res. 1997; 7: 959–66
- Itoh F., Ishizaka Y., Tahira T., Yamamoto M., Miya A., Imai K., Yachi A., Takai S., Sugimura T., Nagao M. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. Oncogene 1992; 7: 1201–6
- Iwamoto T., Taniguchi M., Asai N., Ohkusu K., Nakashima I., Takahashi M. cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. Oncogene 1993; 8: 1087–91
- Lorenzo M.J., Eng C, Mulligan L.M., Stonehouse T.J., Hea-Ley C.S., Ponder B.A., Smith D.P. Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing. Oncogene 1995; 10: 1377–83
- Murines M., Patrone G., Schmitz B., Romeo G., Doer-Fler W. A 5′-CG-3′-rich region in the promoter of the transcriptionally frequently silenced RET protoonco-gene lacks methylated cytidine residues. Oncogene 1998; 17: 2573–83
- Myers S.M., Eng C, Ponder B.A., Mulligan L.M. Characterization of RET proto-oncogene 3′ splicing variants and polyadenylation sites: a novel C-termi-nus for RET. Oncogene 1995; 11: 2039–45
- Pachnis V., Mankoo B., Costantini F. Expression of the c-ret proto-oncogene during mouse embryogene-sis. Development 1993; 119: 1005–17
- Pasini B., Ceccherini I., Romeo G. RET mutations in human disease. Trends Genet. 1996; 12: 138–44
- Saarma M., Sariola H. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microscopy Research and Technique 1999; 45: 292–302
- Santoro M., Rosati R., Grieco M., Berlingieri M.T., D'Amato G.L., de Franciscis V., Fusco A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 1990; 5: 1595–8
- Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994; 367: 380–3
- Schuchardt A., Srinivas S., Pachnis V., Costantini F. Isolation and characterization of a chicken homolog of the c-ret proto- oncogene. Oncogene 1995; 10: 641–9
- Smith-Hicks C.L., Sizer K.C., Powers J.F., Tischler A.S., Costantini F. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J 2000; 19(4)612–22